Drug Discovery Outsourcing Market by Workflow (Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening), Therapeutics Area (Anti-Infective, Cardiovascular, Central Nervous System), Type, End-User - Global Forecast 2023-2030
The Drug Discovery Outsourcing Market size was estimated at USD 3.69 billion in 2022 and expected to reach USD 4.01 billion in 2023, at a CAGR 9.32% to reach USD 7.53 billion by 2030 .
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Drug Discovery Outsourcing Market.
- Based on Workflow, market is studied across Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening, and Target Validation & Functional Informatics. The Target Identification & Screening is projected to witness significant market share during forecast period.
- Based on Therapeutics Area, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Dermatology, Endocrine, Gastrointestinal, Genitourinary System, Hematology, Immunomodulation, Oncology, Ophthalmology, Pain & Anesthesia, and Respiratory System. The Respiratory System is projected to witness significant market share during forecast period.
- Based on Type, market is studied across Biology Services and Chemistry Services. The Biology Services is projected to witness significant market share during forecast period.
- Based on End-User, market is studied across Academic Institutes and Pharmaceutical & Biotechnology companies. The Pharmaceutical & Biotechnology companies is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Drug Discovery Outsourcing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Drug Discovery Outsourcing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Drug Discovery Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Curia Global, Inc., Dalton Pharma Services, Eurofins DiscoverX Products, Evotec SE, GenScript Biotech Corporation, Jubilant Biosys Ltd., Laboratory Corporation of America Holdings, Merck & Co., Inc., Oncodesign Precision Medicine, PPD Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Drug Discovery Outsourcing Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Drug Discovery Outsourcing Market?
- What is the competitive strategic window for identifying opportunities in the Drug Discovery Outsourcing Market?
- What are the latest technology trends and regulatory frameworks in the Drug Discovery Outsourcing Market?
- What is the market share of the leading vendors in the Drug Discovery Outsourcing Market?
- Which modes and strategic moves are suitable for entering the Drug Discovery Outsourcing Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Drug Discovery Outsourcing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
- 5.1.1.2. Increasing pharmaceutical R&D investment
- 5.1.1.3. Rising demand for generic drugs and biologic innovation
- 5.1.2. Restraints
- 5.1.2.1. Compliance issues while outsourcing
- 5.1.3. Opportunities
- 5.1.3.1. Increased focus on personalized medicine
- 5.1.3.2. Growing number of biologics pipeline and growing contract manufacturing service
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Drug Discovery Outsourcing Market, by Workflow
- 6.1. Introduction
- 6.2. Lead Identification & Candidate Optimization
- 6.3. Preclinical Development
- 6.4. Target Identification & Screening
- 6.5. Target Validation & Functional Informatics
- 7. Drug Discovery Outsourcing Market, by Therapeutics Area
- 7.1. Introduction
- 7.2. Anti-Infective
- 7.3. Cardiovascular
- 7.4. Central Nervous System
- 7.5. Dermatology
- 7.6. Endocrine
- 7.7. Gastrointestinal
- 7.8. Genitourinary System
- 7.9. Hematology
- 7.10. Immunomodulation
- 7.11. Oncology
- 7.12. Ophthalmology
- 7.13. Pain & Anesthesia
- 7.14. Respiratory System
- 8. Drug Discovery Outsourcing Market, by Type
- 8.1. Introduction
- 8.2. Biology Services
- 8.3. Chemistry Services
- 9. Drug Discovery Outsourcing Market, by End-User
- 9.1. Introduction
- 9.2. Academic Institutes
- 9.3. Pharmaceutical & Biotechnology companies
- 10. Americas Drug Discovery Outsourcing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Drug Discovery Outsourcing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Drug Discovery Outsourcing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Charles River Laboratories
- 14.1.2. Curia Global, Inc.
- 14.1.3. Dalton Pharma Services
- 14.1.4. Eurofins DiscoverX Products
- 14.1.5. Evotec SE
- 14.1.6. GenScript Biotech Corporation
- 14.1.7. Jubilant Biosys Ltd.
- 14.1.8. Laboratory Corporation of America Holdings
- 14.1.9. Merck & Co., Inc.
- 14.1.10. Oncodesign Precision Medicine
- 14.1.11. PPD Inc.
- 14.1.12. Thermo Fisher Scientific Inc.
- 14.1.13. WuXi AppTec
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook